chrX-104658929-C-T
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The ENST00000372582.6(IL1RAPL2):c.16C>T(p.Leu6Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000378 in 1,203,410 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 147 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
ENST00000372582.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
IL1RAPL2 | NM_017416.2 | c.16C>T | p.Leu6Phe | missense_variant | 2/11 | ENST00000372582.6 | NP_059112.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IL1RAPL2 | ENST00000372582.6 | c.16C>T | p.Leu6Phe | missense_variant | 2/11 | 1 | NM_017416.2 | ENSP00000361663 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000403 AC: 45AN: 111766Hom.: 0 Cov.: 24 AF XY: 0.000265 AC XY: 9AN XY: 33978
GnomAD3 exomes AF: 0.000337 AC: 60AN: 178003Hom.: 0 AF XY: 0.000397 AC XY: 25AN XY: 62965
GnomAD4 exome AF: 0.000376 AC: 410AN: 1091644Hom.: 0 Cov.: 28 AF XY: 0.000386 AC XY: 138AN XY: 357704
GnomAD4 genome AF: 0.000403 AC: 45AN: 111766Hom.: 0 Cov.: 24 AF XY: 0.000265 AC XY: 9AN XY: 33978
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 27, 2022 | The c.16C>T (p.L6F) alteration is located in exon 2 (coding exon 1) of the IL1RAPL2 gene. This alteration results from a C to T substitution at nucleotide position 16, causing the leucine (L) at amino acid position 6 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Oct 01, 2022 | IL1RAPL2: BS2 - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at